News on Catholic University Leuven from BioPortfolio.com http://www.BioPortfolio.com Consolidated Catholic University Leuven news from BioPortfolio.com Wed, 10 Feb 2010 15:44:43 GMT en ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038827&HITNO=0&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038827&THISHREF=http://c.moreover.com/click/here.pl%3fz2537788825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038827&HITNO=0&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038827&THISHREF=http://c.moreover.com/click/here.pl%3fz2537788825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: IMEC and Holst Centre achieve breakthrough in battery-less radioshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038719&HITNO=1&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038719&THISHREF=http://c.moreover.com/click/here.pl%3fz2537725810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038719&HITNO=1&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038719&THISHREF=http://c.moreover.com/click/here.pl%3fz2537725810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033635&HITNO=2&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033635&THISHREF=http://c.moreover.com/click/here.pl%3fz2535298573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033635&HITNO=2&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033635&THISHREF=http://c.moreover.com/click/here.pl%3fz2535298573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Review Spotlights Clues to Serious Childhood Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024249&HITNO=3&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024249&THISHREF=http://c.moreover.com/click/here.pl%3fz2528731492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024249&HITNO=3&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024249&THISHREF=http://c.moreover.com/click/here.pl%3fz2528731492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicineNet.com: Red Flags for Serious Infection in Children Highlightedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008840&HITNO=4&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008840&THISHREF=http://c.moreover.com/click/here.pl%3fz2521720898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008840&HITNO=4&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008840&THISHREF=http://c.moreover.com/click/here.pl%3fz2521720898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Medicine: GPs should 'listen to parent's concerns' on child infectionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005452&HITNO=5&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005452&THISHREF=http://c.moreover.com/click/here.pl%3fz2520365928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005452&HITNO=5&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005452&THISHREF=http://c.moreover.com/click/here.pl%3fz2520365928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPulse: Red Flags Warning Of Serious Infection In Children In Developed Countrieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004169&HITNO=6&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004169&THISHREF=http://c.moreover.com/click/here.pl%3fz2519845273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004169&HITNO=6&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004169&THISHREF=http://c.moreover.com/click/here.pl%3fz2519845273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Herceptin now approved in the EU for patients with HER2-positive advanced stomach cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995311&HITNO=7&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995311&THISHREF=http://c.moreover.com/click/here.pl%3fz2515592108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995311&HITNO=7&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995311&THISHREF=http://c.moreover.com/click/here.pl%3fz2515592108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Herceptin now approved in the EU for patients withhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991101&HITNO=8&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991101&THISHREF=http://c.moreover.com/click/here.pl%3fz2513559687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991101&HITNO=8&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991101&THISHREF=http://c.moreover.com/click/here.pl%3fz2513559687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Europe: Roche gets EU approval for Herceptin to treat HER2-positive advanced stomach cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980418&HITNO=9&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980418&THISHREF=http://c.moreover.com/click/here.pl%3fz2506385810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980418&HITNO=9&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980418&THISHREF=http://c.moreover.com/click/here.pl%3fz2506385810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Herceptin Approved in the EU for Patients with HER2-positive Advanced Stomach Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980171&HITNO=10&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980171&THISHREF=http://c.moreover.com/click/here.pl%3fz2506247675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980171&HITNO=10&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980171&THISHREF=http://c.moreover.com/click/here.pl%3fz2506247675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Herceptin now approved in the EU for patients with HER2-positive advanced stomach cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974986&HITNO=11&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974986&THISHREF=http://c.moreover.com/click/here.pl%3fz2503829454%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974986&HITNO=11&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974986&THISHREF=http://c.moreover.com/click/here.pl%3fz2503829454%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Europe: Transplanted Trachea Grows Own Blood Supply in Patient's Armhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912270&HITNO=12&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912270&THISHREF=http://c.moreover.com/click/here.pl%3fz2470132966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912270&HITNO=12&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912270&THISHREF=http://c.moreover.com/click/here.pl%3fz2470132966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicineNet.com: Nektar Therapeutic gets positive results of NKTR-102 from 1st stage of phase-2 study in platinum-resistant ovahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907221&HITNO=13&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907221&THISHREF=http://c.moreover.com/click/here.pl%3fz2467343776%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907221&HITNO=13&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907221&THISHREF=http://c.moreover.com/click/here.pl%3fz2467343776%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Adjuvant radiation therapy may delay post-radical prostatectomy cancer progressionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905453&HITNO=14&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905453&THISHREF=http://c.moreover.com/click/here.pl%3fz2466284832%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905453&HITNO=14&MSIZE=28&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Catholic%20University%20Leuven&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905453&THISHREF=http://c.moreover.com/click/here.pl%3fz2466284832%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Medicine: